BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10568824)

  • 1. Endogenous interleukin-12: relationship with angiogenic factors, hormone receptors and nodal status in human breast carcinoma.
    Toi M; Gion M; Saji H; Asano M; Dittadi R; Gilberti S; Locopo N; Gasparini G
    Int J Oncol; 1999 Dec; 15(6):1169-75. PubMed ID: 10568824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
    Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
    J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
    Eppenberger U; Kueng W; Schlaeppi JM; Roesel JL; Benz C; Mueller H; Matter A; Zuber M; Luescher K; Litschgi M; Schmitt M; Foekens JA; Eppenberger-Castori S
    J Clin Oncol; 1998 Sep; 16(9):3129-36. PubMed ID: 9738585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.
    Giatromanolaki A; Koukourakis MI; Stathopoulos GP; Kapsoritakis A; Paspatis G; Kakolyris S; Sivridis E; Georgoulias V; Harris AL; Gatter KC
    Oncol Res; 2000; 12(1):33-41. PubMed ID: 11061344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma.
    Linderholm B; Lindh B; Tavelin B; Grankvist K; Henriksson R
    Int J Cancer; 2000 Jan; 89(1):51-62. PubMed ID: 10719731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.
    Leek RD; Landers R; Fox SB; Ng F; Harris AL; Lewis CE
    Br J Cancer; 1998 Jun; 77(12):2246-51. PubMed ID: 9649140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
    MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
    Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor and prognosis in patients with node-negative breast cancer.
    De Paola F; Granato AM; Scarpi E; Monti F; Medri L; Bianchi S; Amadori D; Volpi A
    Int J Cancer; 2002 Mar; 98(2):228-33. PubMed ID: 11857413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
    Sivridis E; Giatromanolaki A; Anastasiadis P; Georgiou L; Gatter KC; Harris AL; Bicknell R; Koukourakis MI;
    J Pathol; 2002 Apr; 196(4):416-22. PubMed ID: 11920737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.
    Ueno T; Toi M; Saji H; Muta M; Bando H; Kuroi K; Koike M; Inadera H; Matsushima K
    Clin Cancer Res; 2000 Aug; 6(8):3282-9. PubMed ID: 10955814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer.
    Leek RD; Hunt NC; Landers RJ; Lewis CE; Royds JA; Harris AL
    J Pathol; 2000 Mar; 190(4):430-6. PubMed ID: 10699991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
    Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
    Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiogenic factors: coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma.
    Eisma RJ; Spiro JD; Kreutzer DL
    Laryngoscope; 1999 May; 109(5):687-93. PubMed ID: 10334214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
    Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
    Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
    Linderholm B; Tavelin B; Grankvist K; Henriksson R
    J Clin Oncol; 1998 Sep; 16(9):3121-8. PubMed ID: 9738584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].
    Wu H; Li Y; Zhu G; Zhang L; Zhang X; He X
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(10):708-11. PubMed ID: 12133473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma.
    Kurizaki T; Toi M; Tominaga T
    Oncol Rep; 1998; 5(3):673-7. PubMed ID: 9538174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis.
    Relf M; LeJeune S; Scott PA; Fox S; Smith K; Leek R; Moghaddam A; Whitehouse R; Bicknell R; Harris AL
    Cancer Res; 1997 Mar; 57(5):963-9. PubMed ID: 9041202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.